Guide · Law & labelling

Ingredients banned in Europe - and what a US supplement brand should do about them

A US formula that sells legally at home can break three separate EU rules and one Polish list. Run every US or UK formula sheet against the table below; each line has its source.

Published 29 October 2026Reading time 12 minAuthor

Short answer

Ingredients banned in Europe for food supplements fall into four groups: substances prohibited or restricted under Annex III of Regulation (EC) No 1925/2006 (for example ephedra, yohimbe and aloe-emodin are prohibited; monacolins from red yeast rice and green tea EGCG are capped), novel foods not yet authorised on the Union list (for example CBD), food additives removed from the EU list (titanium dioxide, E 171), and national bans. Poland has its own list in Dz.U. 2024 poz. 420, which includes DMAA, higenamine, hordenine, SARMs and kava. Check every ingredient against all four before you file a GIS notification.

Why US supplement ingredients are not allowed in the EU

In the US, a supplement ingredient is usually legal until the FDA acts against it. In the EU the logic runs the other way for many categories: some substances are listed as prohibited, new ingredients need prior authorisation, and additives must be on a positive list. We cover the wider differences between DSHEA and EU food law in our guide for US brands entering the EU. Here we stay with the ingredients.

Four separate mechanisms remove an ingredient from a Polish formula:

MechanismLegal basisWhat it doesTypical US ingredients caught
Annex III, Part ARegulation (EC) No 1925/2006, Article 8Prohibits a substance in foodEphedra, yohimbe, aloe-emodin and emodin
Annex III, Part BSameAllows a substance only under conditions, with label warningsRed yeast rice, green tea extract
Novel food without authorisationRegulation (EU) 2015/2283, Article 6(2)Only authorised novel foods on the Union list may be soldCBD, NMN
Food additive removedRegulation (EU) 2022/63Deletes or limits an additiveTitanium dioxide (E 171) in coatings
National listDz.U. 2024 poz. 420 (Poland)Bans named substances in all food, including supplementsDMAA, higenamine, hordenine, SARMs, MK-677

An ingredient can be clean under one mechanism and blocked under another. Run all four.

Substances restricted under Annex III: Parts A, B and C

Annex III of Regulation (EC) No 1925/2006 is the EU's list for "other substances" added to food. Its three parts are headed "Part A - Prohibited substances", "Part B - Restricted substances" and "Part C - Substances under Community scrutiny".

Article 8(2) explains the split. Where harmful effects are identified, the Commission puts the substance in Part A or Part B. Part C is used "if the possibility of harmful effects on health is identified but scientific uncertainty persists" (Regulation (EC) No 1925/2006, Article 8(2)). Part C is a waiting room, not a permission: "Within four years from the date a substance has been listed in Annex III, Part C," the Commission has to decide whether to allow it or move it to Part A or B (Article 8(5)).

Yohimbe shows how that ends. It sat in Part C; when "interested parties have not submitted any scientific data to the Authority" within the time limit, it was moved to Part A (Regulation (EU) 2019/650, recital 4). If your formula contains a Part C botanical today, plan as if it could become Part A within the life of your SKU.

Ingredients banned in Europe: the table

Each line below links to the act we read. Status is as of 29 October 2026; always open the consolidated Annex III on EUR-Lex before you finalise a formula.

Ingredient (as sold in the US)EU statusSourceFor a Polish SKU
Ephedra (ma huang)Part A, prohibited: "Ephedra herb and its preparations originating from Ephedra species"Reg. (EU) 2015/403Remove
Yohimbe barkPart A, prohibited: "Yohimbe bark and its preparations originating from Yohimbe (Pausinystalia yohimbe (K. Schum) Pierre ex Beille)"Reg. (EU) 2019/650Remove. Poland also bans yohimbine hydrochloride and the yohimbine group
Aloe leaf "detox" and laxative blendsPart A: aloe-emodin, emodin, danthron and "preparations from the leaf of Aloe species containing hydroxyanthracene derivatives"Reg. (EU) 2021/468Remove leaf preparations containing these derivatives
Senna, rhubarb root, cascara / frangula barkPart C, under scrutiny: preparations containing hydroxyanthracene derivativesReg. (EU) 2021/468High risk. Plan a replacement
Red yeast ricePart B: daily portion "shall provide less than 3 mg of monacolins from red yeast rice."Reg. (EU) 2022/860Reformulate under 3 mg and add the mandatory warnings
Green tea extract (EGCG)Part B: daily portion "shall contain less than 800 mg of (-)-epigallocatechin-3-gallate"Reg. (EU) 2022/2340Reformulate under 800 mg and add the warnings
Titanium dioxide (E 171) in tablet or capsule coatingsDeleted from the Group II colours authorised at quantum satis; new footnote: "Titanium dioxide is not authorised in the food categories listed in Part D and E." Sell-off for older stock ran until 7 August 2022Reg. (EU) 2022/63Switch the coating or capsule colour
CBDNovel food, not authorisedEFSA, 7 June 2022; AESAN, 12 February 2026Do not sell as food
NMNNovel food; draft authorisation discussed in September 2026Czech consultation result; PAFF agenda, 25 September 2026Do not sell until it is on the Union list (to be confirmed at launch)
DMAA, higenamine, hordenine, SARMs, MK-677 (pre-workout and "sports" products)Banned in Poland by national regulationDz.U. 2024 poz. 420Remove

Restricted, not banned: red yeast rice and green tea extract

Part B substances stay legal, but the label has to carry fixed warnings. US labels almost never have them, so a sticker translation fails. For red yeast rice, Regulation (EU) 2022/860 requires, among others:

  • "The label shall indicate the content of monacolins per portion of the product."
  • A warning "not to consume a daily amount of 3 mg of monacolins from red yeast rice or more"
  • "Should not be consumed by pregnant or lactating women, children below 18 years old and adults above 70 years old"
  • "Should not be consumed if you are taking cholesterol-lowering medication"
  • "Should not be consumed if you are already consuming other products containing red yeast rice"

For green tea extracts with EGCG, Regulation (EU) 2022/2340 requires the content of EGCG per portion, a warning not to consume 800 mg or more a day, and statements including "Should not be consumed on an empty stomach" and "Should not be consumed by pregnant or lactating women and children below 18 years old". The same act also lists green tea extracts containing EGCG in Part C, with an exclusion for aqueous extracts comparable to traditional green tea infusions, so the substance remains under review.

All of these warnings must appear in Polish on the pack. Plan the label space early; our Polish label guide covers the mandatory elements around them.

NMN EU status and CBD: novel food, not banned

NMN and CBD are often described online as "banned in Europe". Legally they are something else: novel foods without an authorisation, which means they cannot be sold as food until the Commission adds them to the Union list. The difference matters, because a novel food can become legal overnight when an implementing regulation is published.

NMN

In a consultation answered by the Czech Republic, the Commission published the conclusion: "The ingredient is considered a novel food.", under category 3(2)(a)(i) (consultation result on nicotinamide mononucleotide). The agenda of the Standing Committee section on novel food for 25 September 2026 included a draft implementing regulation "authorising the placing on the market of betanicotinamide mononucleotide (beta-NMN)" (PAFF Committee agenda). Whether that act has been adopted and published, and under what conditions, is to be confirmed on EUR-Lex on the day you plan. Until it is in force, NMN cannot be sold in Poland, and when it is, you must match its specification, maximum level and labelling.

CBD

EFSA said on 7 June 2022 that it "cannot currently establish the safety of cannabidiol (CBD) as a novel food" and put 19 applications on hold (EFSA news). The Spanish food safety agency reported on 12 February 2026 that EFSA had published a provisional update with a level of 0.0275 mg per kg body weight per day, roughly 2 mg of CBD a day for a 70 kg adult, under strict conditions, and that CBD in food, including supplements, remains not permitted until authorised by the Commission (AESAN, our translation). A provisional EFSA level is not an authorisation.

Poland's own list of banned supplement ingredients

Poland adds a national layer. The annex to the Minister of Health Regulation of 13 March 2024 (Dz.U. 2024 poz. 420) is titled "Wykaz substancji innych niż witaminy i składniki mineralne zakazanych w produkcji środków spożywczych", a list of non-vitamin, non-mineral substances banned in food production. GIS confirms that it covers food supplements (GIS, gov.pl).

No.Substance (Polish annex wording, English)Where US brands meet it
1Yohimbine hydrochloride and the yohimbine groupFat burners, libido products
2DMAA (1,3-dimethylamylamine and listed synonyms)Pre-workouts
3EvodiamineThermogenics
4SARMs, including andarine (S-4), ligandrol (LGD-4033), ostarine (enobosarm), RAD-140 (testolone)"Research" sports products
5HigenaminePre-workouts, fat burners
6HordeninePre-workouts, focus blends
7Ibutamoren (MK-677)Sports and "longevity" products
8PancreatinDigestive enzyme blends
9Kava (Piper methysticum)Relaxation and sleep blends
10Velvet bean (Mucuna pruriens)Dopamine and mood blends
11Greater celandine (Chelidonium majus L.), added in 2026Liver and digestive herbal blends

Point 11 was added by the Minister of Health Regulation of 16 March 2026 (Dz.U. 2026 poz. 371). Both acts allow food already on the market before entry into force to stay on sale for no more than 30 days after it. In other words: when Poland adds a substance, you have weeks, not a sell-through year. Check enzyme blends for pancreatin and mood blends for Mucuna in particular.

Is ashwagandha banned in Europe?

Not at EU level on the evidence we could verify. Ashwagandha (Withania somnifera) does not appear in the Polish national list above, including the 2026 amendment. We could not confirm an ashwagandha entry in Annex III from the acts we read, so treat the EU position as to be confirmed against the consolidated Annex III on the day you act.

What official bodies have said is a risk assessment, not a ban. Germany's BfR, in Communication 39/2024 of 10 September 2024, found the data "not sufficient to allow a conclusive risk assessment" and advised that ashwagandha supplements should not be taken by "especially children, pregnant and breastfeeding women and people with acute or pre-existing liver disease" (BfR).

Reports of national bans or planned bans in other Member States circulate in trade media. We have not confirmed them on an official national authority site, so we do not list them here. For a Polish launch: ashwagandha is sellable today, but put risk-group warnings on the label, keep the dose conservative and documented, and watch for EU action. We explain dose practice in Poland in our guide to novel food and maximum doses.

Reformulate, apply or drop: what to do with a flagged ingredient

For each red line in the table, pick one route and write it down. Run this sequence:

  1. List every ingredient with its exact identity. Latin name, plant part, extract ratio, chemical form, and the additives in the capsule shell and coating. E 171 hides in the coating, not in the active list.
  2. Run the four checks. Annex III (consolidated), the Union list and novel food status (Commission novel food catalogue), the additives list, and the Polish annex to Dz.U. 2024 poz. 420.
  3. Remove Part A and Polish-list substances. No dossier fixes these. Replace or drop.
  4. Recalculate Part B doses per daily portion. Red yeast rice under 3 mg monacolins, EGCG under 800 mg, then add every mandatory warning in Polish.
  5. Decide on Part C botanicals. Legal today, under review. Keep only if the SKU still works without them.
  6. Park novel foods. No NMN or CBD in the Polish SKU until an authorisation is in force. Prepare a version that can switch in when it is.
  7. Lock the Polish specification. Only then brief the manufacturer or set up the import and prepare the GIS notification.
RouteWhen it fitsTrade-off
ReformulatePart B dose too high, Part C botanical, E 171 coatingNew stability and label work; usually the fastest route to shelf
ApplyNovel food central to the brand, with a long horizonYears, data costs, no sales of that ingredient meanwhile
DropPart A, Polish list, or a minor ingredientFormula story changes; claims may need rework

Sources

Primary legal texts and official pages used in this guide. Always read the consolidated version in force on the day you act.

  1. Regulation (EC) No 1925/2006 on the addition of vitamins, minerals and certain other substances to foods - EUR-Lex
  2. Commission Regulation (EU) 2015/403 (ephedra) - EUR-Lex
  3. Commission Regulation (EU) 2019/650 (yohimbe) - EUR-Lex
  4. Commission Regulation (EU) 2021/468 (hydroxyanthracene derivatives) - EUR-Lex
  5. Commission Regulation (EU) 2022/860 (monacolins from red yeast rice) - EUR-Lex
  6. Commission Regulation (EU) 2022/2340 (green tea extracts containing EGCG) - EUR-Lex
  7. Commission Regulation (EU) 2022/63 (titanium dioxide, E 171) - EUR-Lex
  8. Regulation (EU) 2015/2283 on novel foods - EUR-Lex
  9. European Commission - Novel Food status Catalogue
  10. European Commission - consultation result on nicotinamide mononucleotide (Czech Republic)
  11. European Commission - PAFF Committee, Section Novel Food and Toxicological Safety, agenda of 25 September 2026
  12. EFSA - Cannabidiol novel food evaluations on hold pending new data (7 June 2022)
  13. AESAN (Spanish Agency for Food Safety and Nutrition) - update on the safety of CBD as a novel food (12 February 2026)
  14. Minister of Health Regulation of 13 March 2024 on fortifying substances added to food (Dz.U. 2024 poz. 420) - ISAP/ELI
  15. Minister of Health Regulation of 16 March 2026 amending it (Dz.U. 2026 poz. 371) - ELI
  16. GIS - Substances and plant materials not permitted in food supplements (gov.pl)
  17. BfR - Ashwagandha: food supplements with potential health risks, Communication 39/2024

This is not legal advice. Annex III, the Union list and national lists change; check the consolidated versions on the day you act and take legal advice for borderline ingredients.

Frequently asked questions

Which supplement ingredients are banned in Europe?
At EU level, Annex III Part A of Regulation (EC) No 1925/2006 prohibits substances such as ephedra, yohimbe, aloe-emodin, emodin, danthron and aloe leaf preparations with hydroxyanthracene derivatives. Unauthorised novel foods and removed additives such as E 171 are also out.
Is ashwagandha banned in Europe?
We found no EU-level ban and no entry in Poland's national list. Germany's BfR advises risk groups against it, which is a risk assessment, not a ban. Check the consolidated Annex III before launch.
What is the NMN EU status?
NMN was classified as novel food in a consultation published by the Commission. A draft authorisation was on the committee agenda on 25 September 2026; check EUR-Lex for whether it has been adopted before you plan a Polish SKU.
What are the substances restricted under Annex III?
Part B lists substances allowed only under conditions, such as monacolins from red yeast rice below 3 mg a day and green tea EGCG below 800 mg a day, each with mandatory label warnings.
Are US supplement ingredients not allowed in the EU also banned in Poland?
Yes, EU rules apply in Poland directly. Poland adds its own list of banned substances, including DMAA, higenamine, hordenine, SARMs, MK-677, kava and Mucuna pruriens.
Can I sell CBD supplements in Poland?
Not as food. CBD is a novel food without EU authorisation. A provisional EFSA safe level published in 2026 does not change that until the Commission authorises it.

Read next

Guide · Market entryUS supplement brands entering the EU: what changes from DSHEAFDA registration, NDI status and the FDA disclaimer do not carry over. Here is what a US brand has to rebuild for Europe - and the legal texts on both sides.Checklist · Law & labellingNovel food status and maximum doses in Poland: what to check before launchTwo questions decide whether your formula can enter Poland unchanged: is every ingredient allowed in food, and are your doses in line with Polish practice. Both are easy to check early and expensive to discover late.Guide · Market entryImporting supplements from the UK or the US into PolandFor UK and US brands, Poland is not just a new market but a new regulatory system. The product that sells well at home is the starting point, not the finished article. Here is what changes and how to handle it.

US brand, EU plan? Start with the formula, not the sticker.

Send us your US label and formula. We will show you what has to change for the EU and for Poland before you commit stock.

Contact us